MARKET

AVCO

AVCO

AVALON GLOBOCARE
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.270
+0.040
+3.25%
After Hours: 1.280 +0.01 +0.79% 18:56 11/25 EST
OPEN
1.250
PREV CLOSE
1.230
HIGH
1.290
LOW
1.210
VOLUME
527.11K
TURNOVER
--
52 WEEK HIGH
2.500
52 WEEK LOW
0.5000
MARKET CAP
103.38M
P/E (TTM)
-6.5633
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
No Data
Forecast
EPSBVPSCFPS
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of AVCO. Analyze the recent business situations of AVALON GLOBOCARE through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Institutional Holdings
Institutions: 44
Institutional Holdings: 3.16M
% Owned: 3.88%
Shares Outstanding: 81.40M
TypeInstitutionsShares
Increased
10
107.54K
New
10
-48.51K
Decreased
11
82.13K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+2.74%
Pharmaceuticals & Medical Research
+0.82%
Key Executives
Chairman/Director
Lu Wenzhao
President/Chief Executive Officer/Director
David Jin
Chief Financial Officer
Luisa Ingargiola
Chief Operating Officer/Secretary/Director
Li Meng
Director
Wilbert Tauzin
Independent Director
Steven Sanders
Independent Director
William Stilley
Independent Director
Tevi Troy
Independent Director
Lu Yancen
Independent Director
Li Yue
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About AVCO
Avalon GloboCare Corp. is an intelligent biotech developer and healthcare service provider. The Company engages in the management of stem cell banks and specialty clinical laboratories. It is developing of exosome technology to improve the diagnosis and management of diseases. The Company operates through two platforms, Avalon Cell and Avalon Rehab. Its technology and service ecosystem covers the areas of regenerative medicine, cell-based immunotherapy, exosome technology, as well as rehabilitation medicine. The Company also focused on diagnostic advancements in the fields of oncology, infectious diseases and fibrotic diseases, and the discovery of disease-specific exosomes to provide the disease origin insight necessary to enable.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Avalon Globocare Corp stock information, including NASDAQ:AVCO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AVCO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AVCO stock methods without spending real money on the virtual paper trading platform.